Ovation Science Inc.
OVAT
CNSX
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 10.60K | 30.90K | 30.00K | 10.90K | 3.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 10.60K | 30.90K | 30.00K | 10.90K | 3.30K |
| Cost of Revenue | 2.00K | 800.00 | 15.10K | 11.60K | 1.00K |
| Gross Profit | 8.60K | 30.10K | 14.90K | -700.00 | 2.30K |
| SG&A Expenses | 90.10K | 123.10K | 120.80K | 161.30K | 115.20K |
| Depreciation & Amortization | 400.00 | 600.00 | 600.00 | 600.00 | 600.00 |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 92.80K | 126.00K | 143.10K | 149.50K | 123.00K |
| Operating Income | -82.20K | -95.20K | -113.10K | -138.60K | -119.80K |
| Income Before Tax | -130.60K | -55.40K | -130.60K | -141.10K | -144.00K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -130.60K | -55.40K | -130.60K | -141.10K | -144.00K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -130.60K | -55.40K | -130.60K | -141.10K | -144.00K |
| EBIT | -82.20K | -95.20K | -113.10K | -138.60K | -119.80K |
| EBITDA | -81.80K | -94.60K | -112.50K | -138.00K | -119.20K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 35.24M | 29.37M | 34.19M | 33.16M | 29.37M |
| Average Diluted Shares Outstanding | 35.24M | 29.37M | 34.19M | 33.16M | 29.37M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |